Conditions: Diabetic Neuropathy, Painful
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 123
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and efficacy of the long-term use of pregabalin at doses up to 600 mg/day in patients with painful diabetic peripheral neuropathy who have completed 13 weeks of dosing in Study A0081163

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: pregabalin
Intervention descriptions: intervention 1: Dosage: 150-600 mg/day (75-300 mg bid), oral administration, Treatment duration: 52 weeks

Protocol document: